Waters Co. (NYSE:WAT) Expected to Post FY2022 Earnings of $12.05 Per Share

Waters Co. (NYSE:WATGet Rating) – Analysts at Jefferies Financial Group raised their FY2022 earnings per share (EPS) estimates for shares of Waters in a research report issued on Wednesday, May 4th. Jefferies Financial Group analyst B. Couillard now forecasts that the medical instruments supplier will earn $12.05 per share for the year, up from their prior estimate of $11.80. Jefferies Financial Group also issued estimates for Waters’ Q4 2022 earnings at $3.98 EPS and FY2023 earnings at $13.15 EPS.

WAT has been the topic of several other reports. Wells Fargo & Company upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and dropped their target price for the stock from $320.00 to $315.00 in a report on Monday, April 25th. SVB Leerink lowered their price objective on shares of Waters from $375.00 to $350.00 and set a “market perform” rating on the stock in a report on Wednesday, February 2nd. Finally, StockNews.com started coverage on shares of Waters in a report on Thursday, March 31st. They issued a “buy” rating on the stock. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Waters has an average rating of “Hold” and a consensus target price of $373.83.

Shares of WAT stock opened at $327.93 on Monday. The company has a debt-to-equity ratio of 4.12, a quick ratio of 1.87 and a current ratio of 1.03. The company has a market capitalization of $19.81 billion, a P/E ratio of 28.69, a price-to-earnings-growth ratio of 3.08 and a beta of 0.85. The company’s 50 day moving average price is $314.47 and its two-hundred day moving average price is $331.07. Waters has a 52 week low of $288.32 and a 52 week high of $428.22.

Waters (NYSE:WATGet Rating) last announced its earnings results on Tuesday, May 3rd. The medical instruments supplier reported $2.80 EPS for the quarter, topping the consensus estimate of $2.33 by $0.47. The firm had revenue of $690.60 million for the quarter, compared to the consensus estimate of $634.08 million. Waters had a net margin of 24.57% and a return on equity of 221.08%. The business’s quarterly revenue was up 13.5% on a year-over-year basis. During the same period last year, the company posted $2.29 EPS.

A number of institutional investors and hedge funds have recently modified their holdings of WAT. Norges Bank acquired a new position in Waters during the fourth quarter worth $189,516,000. BlackRock Inc. increased its holdings in Waters by 5.8% during the fourth quarter. BlackRock Inc. now owns 6,069,554 shares of the medical instruments supplier’s stock worth $2,261,515,000 after buying an additional 331,610 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Waters by 16.9% during the third quarter. Arrowstreet Capital Limited Partnership now owns 928,808 shares of the medical instruments supplier’s stock worth $331,863,000 after buying an additional 134,304 shares during the last quarter. Invesco Ltd. boosted its position in Waters by 15.5% during the fourth quarter. Invesco Ltd. now owns 969,123 shares of the medical instruments supplier’s stock worth $361,093,000 after purchasing an additional 129,837 shares during the period. Finally, Schroder Investment Management Group boosted its position in Waters by 124.6% during the fourth quarter. Schroder Investment Management Group now owns 229,736 shares of the medical instruments supplier’s stock worth $85,599,000 after purchasing an additional 127,458 shares during the period. Institutional investors and hedge funds own 90.65% of the company’s stock.

Waters Company Profile (Get Rating)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.